Intraperitoneal Paclitaxel for Patients With Primary Malignant Peritoneal Mesothelioma
NCT05449366
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
7
Enrollment
OTHER
Sponsor class
Conditions
Peritoneal Malignant Mesothelioma
Interventions
DRUG:
Intraperitoneal Paclitaxel Solution (Ml)
Sponsor
Erasmus Medical Center